VRAX icon

Virax Biolabs

4 hedge funds and large institutions have $71.5K invested in Virax Biolabs in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-3
Holders Change %
-42.86%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
1
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
UBS Group
1
UBS Group
Switzerland
$25.6K -$17.7K -15,490 -41%
TSS
2
Two Sigma Securities
New York
$15.5K +$15.5K +13,627 New
Citadel Advisors
3
Citadel Advisors
Florida
$15.4K +$15.4K +13,539 New
HF
4
HRT Financial
New York
$15K +$15K +13,507 New
XT
5
XTX Topco
Cayman Islands
-$26.7K -11,863 Closed
Royal Bank of Canada
6
Royal Bank of Canada
Ontario, Canada
-$23K -10,400 Closed
RS
7
R Squared
Hong Kong
-$6.08K -2,700 Closed
Morgan Stanley
8
Morgan Stanley
New York
-$225 -100 Closed
Northwestern Mutual Wealth Management
9
Northwestern Mutual Wealth Management
Wisconsin
-$45 -20 Closed
TRCT
10
Tower Research Capital (TRC)
New York
-$20 -9 Closed